Resonant light therapy speeds the healing process and boosts your body’s natural ability to repair itself, offering safe and effective wellness benefits that extend far beyond healthcare alone.
Many positive responses have been reported. One such case involved using therapeutic resonant frequencies related to several strains of herpes simplex virus and experiencing its eradication.
Dosage
Resonant light therapy to kill pathogens in the body has been found to have numerous beneficial health outcomes, such as increasing skin cell growth and healing, improving muscle recovery, weight loss, sleep disorders, inflammation reduction and increasing immunity system function. Furthermore, studies have also demonstrated it as increasing collagen production while simultaneously decreasing wrinkles on skin surfaces.
Red and near infrared (NIR) light therapy has been confirmed in over 4,000 clinical studies. It has been demonstrated to stimulate collagen and elastin production, increase circulation, reduce pain levels and aid wound healing; improve energy, cognitive functioning and mood; as well as increasing brain cell growth and activity while slowing neurodegenerative diseases’ progression.
Resonant light therapy could offer great promise in slowing the progression of Parkinson’s disease, by protecting remaining dopaminergic neurons from death and protecting remaining dopaminergic neurons from damage. In order to do this, however, precise dosing would likely be needed and this would likely involve minimally invasive surgery using stereotactic needles in which a tiny light-optical device would be implanted into your brain in close proximity to diseased SNc neurons.
Resonant light therapy‘s beneficial effects on Parkinson’s disease should only be viewed as symptomatic rather than neuroprotective; its impact would likely lie more in stimulating other parts of the neural circuitry affected by loss of dopaminergic neurons rather than directly impacting diseased SNc neurons directly.
Resonant light therapy as an experimental form of treatment for Parkinson’s may still be quite novel; however, its use has received positive responses from users. Experimental evidence shows it to be effective against bacteria and pathogens – making it a viable alternative to antibiotics. Before engaging in any resonant light therapy treatments for your Parkinson’s condition it is recommended to first speak to a healthcare provider to gain diagnosis and create an individualized treatment plan.
Tissue Penetration
Pulsed light increases both peak power and its ability to penetrate deeper tissue layers due to light not being absorbed by hemoglobin in the skin, as is often the case with continuous wave (CW) lasers. Pulsing also allows photon energy resonance which plays an integral part in improving biostimulation, photoimmunomodulation effects of LED lighting as well as increasing effectiveness of LLLT on fibroblasts and collagen.
Resonant light therapy equipment that works effectively combines laser and LED lights in the near infrared, middle infrared, and part of the far infrared wavelengths to produce optimal healing conditions for cells. This combination of frequencies can produce high ATP levels which support cell healing and growth while stimulating mitochondrial energy production. Furthermore, bio-stimulation can reduce pain and inflammation through bio-stimulation processes while inhibiting bradykinin production, modulating Na/K pump mechanisms within cell membranes, modulate Na/K pump mechanisms in cell membranes, modulate Na/K pump mechanisms to produce energy, and stimulating nitric oxide production which promotes relaxation of muscle tissues.
Studies have repeatedly demonstrated resonant light to be more effective than continuous wave light for applications like wound healing, depression management and stroke prevention. Of those studies that directly compared pulsed with continuous wavelight treatments only two were conducted: Kymplova’s research indicated greater benefits from pulsed light treatment while Al-Watban and Zhang found similar outcomes from both.
One possible explanation for this discrepancy could be that CW can yield greater benefits when used alone while PW can offer additional therapeutic gains when applied to patients with co-morbidities. Or it could simply be related to how light can cause either stimulation or inhibition depending on cell type.
Another possibility is that pulsing light allows for multiple photodissociations of nitric oxide molecules from their binding sites on cytochrome c oxidase, leading to more production than with continuous white light illumination – hence its greater efficacy for treating dry eye and meibomian gland dysfunction (MGD). More research must be completed in this area before conclusively testing this theory.
Direct to Skin Contact
Red light therapy panels emitting red light penetrate both epidermis and mitochondrial chromospheres to activate ATP synthesis and increase oxygen carrying capacity of red blood cells, while at the same time stimulating collagen and elastin production within dermis improving elasticity and tone – this process is known as Photobiomodulation (PBM).
PBM as a non-thermal modality does not generate significant heat during treatment; however, some degree of heat generation may still occur if wavelength and dose are incompatible for a particular application. Scattering can also impede delivery, caused by tight-focused beams of light encountering biological tissue and quickly diffusing into photon clouds; an inherent issue associated with any non-thermal light therapy method and can limit effectiveness.
PBM requires setting specific parameters in order to create therapeutic effects such as healing, pain management and biostimulation. Due to differences among biological tissues, accurately predicting responses is challenging.
Variability can be attributed to multiple factors, including cell type and density, vascularity and water content. Furthermore, differences in optical properties of biological barriers like skin may alter light penetration.
As such, it is critical to recognize that results of experimental in vitro and animal studies may not easily transfer over to clinical settings; additionally, differences in wavelengths, pulse frequencies, dosages used may have significant impacts on therapeutic outcomes.
An important consideration when considering light therapy devices is their energy source; pulsed light is often superior to continuous wave (CW). Pulsed systems allow much higher peak power densities without risk of thermal damage; additionally, when coupled with appropriate ON and OFF timings they minimize heat generation thus providing deeper tissue penetration.
Rife Technology, similar to resonant light therapy, employs specific frequencies that resonate with your body’s natural frequencies to create harmonic vibrations that rebalance cells and help it heal itself.
Wavelengths
PDT employs both scattering and absorption processes, which reduce the effective penetration depth of treatment light (d = 1/3m a + m s). Primary tissue constituents – water, fat, elastin, melanin and proteins – have varied optical properties, each possessing wavelength-dependent scattering coefficients and absorption coefficients that determine effective attenuation of treatment light d. Attenuation depends heavily upon incident radiation wavelength and concentration of chromophores within tissue.
Resonant light therapy uses various light sources, such as lasers and LEDs, depending on a range of criteria including desired light characteristics, photosensitiser dosage levels, minimally accessible area geometry and delivery device (optical fibers).
Pulsed light has been demonstrated to produce superior effects in various applications. While the exact reasons remain elusive, they could include its wavelength range between 2.5-10kHz being more suitable to biological systems or even just because biological processes take place on microsecond time scales and thus require short pulsed lights.
Apart from the fundamental advantages offered by coherent sources – such as high coherence and narrow bands for targeting specific PS – non-coherent sources also offer several advantages for PDT therapy. They can operate at higher fluence rates while still providing enough dose to the target tissue, leading to shorter treatment times and higher patient throughput rates.
However, in order to harness the full potential of PDT for cancer and other diseases, many challenges must first be met, including limited light penetration depth, non-ideal photosensitisers, complex dosimetry and complex implementation into clinic. Therefore, new light sources, advanced photosensitisers and measurement devices as well as innovative application strategies are being investigated extensively to overcome these limitations. Likewise, an understanding of physical parameters surrounding light-tissue interaction must also be achieved to further boost its efficacy.
